Donald B. Kohn

Active 1986–2025

162
Papers
22,737
Citations
91
h-index
153
i10-index

Citations

Citations per year for Donald B. Kohn1984: 1 citations1987: 6 citations1988: 5 citations1989: 10 citations1990: 9 citations1991: 13 citations1992: 14 citations1993: 6 citations1994: 24 citations1995: 27 citations1996: 61 citations1997: 80 citations1998: 108 citations1999: 84 citations2000: 125 citations2001: 90 citations2002: 127 citations2003: 89 citations2004: 98 citations2005: 98 citations2006: 86 citations2007: 95 citations2008: 49 citations2009: 82 citations2010: 76 citations2011: 85 citations2012: 91 citations2013: 105 citations2014: 87 citations2015: 159 citations2016: 166 citations2017: 200 citations2018: 217 citations2019: 705 citations2020: 744 citations2021: 758 citations2022: 652 citations2023: 524 citations2024: 828 citations2025: 413 citations2026: 15 citations1985–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,686 citing papers, 33.1% of this breakdownChina: 628 citing papers, 7.8% of this breakdownUnited Kingdom: 538 citing papers, 6.6% of this breakdownGermany: 505 citing papers, 6.2% of this breakdownItaly: 360 citing papers, 4.4% of this breakdownFrance: 329 citing papers, 4.1% of this breakdownCanada: 292 citing papers, 3.6% of this breakdownNetherlands: 227 citing papers, 2.8% of this breakdownJapan: 214 citing papers, 2.6% of this breakdownAustralia: 199 citing papers, 2.5% of this breakdownSwitzerland: 168 citing papers, 2.1% of this breakdownIndia: 160 citing papers, 2% of this breakdown
0%33.1%Other 22.2%

Fields

  • Biochemistry, Genetics and Molecular Biology51.8%
  • Medicine28.6%
  • Immunology and Microbiology14.6%
  • Neuroscience1.7%
  • Engineering1.6%
  • Materials Science0.5%
  • Other1.2%

Topics

  • CRISPR and Genetic Engineering9.9%
  • Virus-based gene therapy research9.9%
  • CAR-T cell therapy research5.9%
  • RNA Interference and Gene Delivery5.8%
  • Immune Cell Function and Interaction3.1%
  • Immunodeficiency and Autoimmune Disorders3%
  • Other62.4%

Coauthors

All papers

Open in search
  1. Gene therapy comes of age

    Authors: , , , , , - Science 2018 cited by 1,378

  2. Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids

    Authors: , , , , , , , , , , , - Nature Methods 2017 cited by 268

  3. Successes and challenges in clinical gene therapy

    Authors: , , - Gene Therapy 2023 cited by 159

  4. Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher S. Seet, Donald B. Kohn, Pin Wang, Xianghong Jasmine Zhou, Matteo Pellegrini, Benjamin Puliafito, Sarah Larson, Lili Yang - Nature Biotechnology 2024 cited by 95

  5. Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells

    Authors: , , , , , , , , , , , , , , - Science Translational Medicine 2016 cited by 495

  6. Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maritess Coronel, Allen Chi-Shing Yu, Krista Chun, Christian E. Casas, Ruixue Zhang, Serena Arduini, Frances Lynn, Mahesh Kudari, Andrea Spezzi, Marco Zahn, Rene Heimke, Ivan Labik, Roberta Parrott, Rebecca H. Buckley, Lilith Reeves, Kenneth Cornetta, Robert Sokolic, Michael S. Hershfield, Manfred Schmidt, Fabio Candotti, Harry L. Malech, Adrian J. Thrasher, H. Bobby Gaspar - New England Journal of Medicine 2021 cited by 218

  7. Human T cell generation is restored in CD3δ severe combined immunodeficiency through adenine base editing

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cell 2023 cited by 82

  8. Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports Medicine 2021 cited by 104

  9. Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew H. Porteus, Qun Xiang, William T. Shearer, Thomas A. Fleisher, Donald B. Kohn, Jennifer M. Puck, Luigi D. Notarangelo, Morton J. Cowan, Richard J. O’Reilly - New England Journal of Medicine 2014 cited by 771

  10. Lentiviral gene therapy for X-linked chronic granulomatous disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter E. Newburger, Frederic D. Bushman, Manuel Grez, H. Bobby Gaspar, David A. Williams, Harry L. Malech, Anne Galy, Adrian J. Thrasher - Nature Medicine 2020 cited by 253

  11. Analyzing CRISPR genome-editing experiments with CRISPResso

    Authors: , , , , , , - Nature Biotechnology 2016 cited by 498

  12. The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2022 cited by 125

  13. Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diana Hu, Anthony J. Infante, Daisy Johnson, Neena Kapoor, Denise M. Kay, Donald B. Kohn, Rachel Lee, Heather K. Lehman, Zhili Lin, Fred Lorey, Aly Abdel‐Mageed, Adrienne Manning, Sean McGhee, Theodore B. Moore, Stanley J. Naides, Luigi D. Notarangelo, Jordan S. Orange, Sung‐Yun Pai, Matthew H. Porteus, Ray Rodríguez, Neil Romberg, John M. Routes, Mary Ruehle, Arye Rubenstein, Carlos A. Saavedra‐Matiz, G. E. M. Scott, Patricia M. Scott, Elizabeth Secord, Christine M. Seroogy, William T. Shearer, Subhadra Siegel, Stacy K. Silvers, E. Richard Stiehm, Robert W. Sugerman, John L. Sullivan, Susan Tanksley, Millard L. Tierce, James Verbsky, Beth Vogel, Rosalyn Walker, Kelly Walkovich, Jolán E. Walter, Richard L. Wasserman, Michael S. Watson, Geoffrey A. Weinberg, Leonard B. Weiner, Heather Wood, Anne Yates, Jennifer M. Puck - JAMA 2014 cited by 673

  14. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theodore B. Moore, Emi Caywood, Mark T. Vander Lugt, Jacob Rozmus, Larisa Broglie, Lolie C. Yu, Ami J. Shah, Jeffrey R. Andolina, Xuerong Liu, Roberta Parrott, Jasmeen Dara, Susan E. Prockop, Caridad Martinez, Malika Kapadia, Soma Jyonouchi, Kathleen E. Sullivan, Jack Bleesing, Sonali Chaudhury, Aleksandra Petrović, Michael D. Keller, Troy C. Quigg, Suhag Parikh, Shalini Shenoy, Christine M. Seroogy, Tamar Rubin, Hélène Decaluwe, John M. Routes, Troy R. Torgerson, Jennifer W. Leiding, Michael A. Pulsipher, Donald B. Kohn, Linda M. Griffith, Élie Haddad, Christopher C. Dvorak, Luigi D. Notarangelo - The Lancet 2023 cited by 113

  15. Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Siwen Hu‐Lieskovan, Paula Kaplan‐Lefko, Satiro De Oliveira, Christopher S. Seet, Sarah Larson, Stephen J. Forman, James R. Heath, Jerome A. Zack, Gay M. Crooks, Caius G. Radu, Antoni Ribas, Donald B. Kohn, Owen N. Witte, Lili Yang - Cell stem cell 2019 cited by 97

  16. Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned

    Authors: , , , - Cell stem cell 2017 cited by 244

  17. Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates

    Authors: , , , , , , , , , , , , , , , , , , - Molecular Therapy 2019 cited by 126

  18. Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2015 cited by 320

  19. Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010–2017

    Authors: , , , , , , , , , , , , , , , , , , , , - PEDIATRICS 2019 cited by 197

  20. A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jerome Ritz, Christine Rivat, Axel Schambach, Kit L. Shaw, Eric A. Sherman, Leslie E. Silberstein, Emmanuelle Six, Fabien Touzot, Alla V. Tsytsykova, Jinhua Xu‐Bayford, Christopher Baum, Frederic D. Bushman, Alain Fischer, Donald B. Kohn, Alexandra H. Filipovich, Luigi D. Notarangelo, Marina Cavazzana, David A. Williams, Adrian J. Thrasher - New England Journal of Medicine 2014 cited by 410

  21. Immune reconstitution and survival of 100 SCID patients post–hematopoietic cell transplant: a PIDTC natural history study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Angela R. Smith, Elizabeth Stenger, Ziyan Yin, William T. Shearer, Thomas A. Fleisher, Rebecca H. Buckley, Christopher C. Dvorak - Blood 2017 cited by 266

  22. Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Owen N. Witte, David Baltimore, James S. Economou, Antoni Ribas - Clinical Cancer Research 2014 cited by 253

  23. Gene Therapies for Primary Immune Deficiencies

    Authors: , - Frontiers in Immunology 2021 cited by 69

  24. A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells

    Authors: , , , , , , , , , , , , , , , - Cell stem cell 2016 cited by 382